Scimago Lab
powered by Scopus
Formerly the IP & Science
business of Thomson Reuters


eISSN: 1643-3750

Get your full text copy in PDF

Time for new indications for statins?

Maciej Banach, Dimitri P. Mikhailidis, Sverre E. Kjeldsen, Jacek Rysz

Med Sci Monit 2009; 15(12): MS1-5

ID: 878258

The role of statins in the treatment and prevention of cardiovascular diseases, such as coronary artery disease, acute coronary syndromes, diabetes or stroke is well established. However, there are still some questions regarding the role of statins in patients with heart failure, hypertension, atrial fibrillation and chronic kidney disease (CKD). This editorial review discusses the current evidence regarding the use of statins in patients with hypertension (with or without dyslipidemia) or CKD. We need new large randomized clinical trials to confirm the potentially beneficial positive results obtained so far.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree